Search research articles
Contact Us
Filters
Showing results (121-130 of 199) with videos related to
Page
of 20
Sort By:
Arthritis Research & Therapy
|
June 15, 2018
Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus
Fulvia Ceccarelli, Carlo Perricone, Tania Colasanti, et al.
Annals of the Rheumatic Diseases
|
February 24, 2021
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists
Roberta Priori, Greta Pellegrino, Serena Colafrancesco, et al.
Plos One
|
September 7, 2017
The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus
Rossana Scrivo, Laura Massaro, Cristiana Barbati, et al.
Clinical and Experimental Rheumatology
|
May 19, 2026
Anti-neutrophil extracellular trap antibodies in autoimmune rheumatic diseases: a suitable biomarker of thrombosis in systemic lupus erythematosus
Silvia Mancuso, Luca Rapino, Valeria Riccieri, et al.
Annals of the Rheumatic Diseases
|
May 8, 2021
Response to: 'Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'' by Smerilli <i>et al</i>
Roberta Priori, Greta Pellegrino, Serena Colafrancesco, et al.
Seminars in Arthritis and Rheumatism
|
May 4, 2017
Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical assessment
Fulvia Ceccarelli, Carlo Perricone, Enrica Cipriano, et al.
Lupus
|
July 25, 2020
Caffeine intake influences disease activity and clinical phenotype in systemic lupus erythematosus patients
Valeria Orefice, Fulvia Ceccarelli, Cristiana Barbati, et al.
Ebiomedicine
|
November 9, 2020
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137<sup>+</sup>T-cells
Alessio Ugolini, Ilaria Grazia Zizzari, Fulvia Ceccarelli, et al.
Reumatismo
|
November 5, 2024
PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors
Cristina Garufi, Silvia Mancuso, Fulvia Ceccarelli, et al.
Journal of Immunology Research
|
January 23, 2016
Genetic Factors in Systemic Lupus Erythematosus: Contribution to Disease Phenotype
Fulvia Ceccarelli, Carlo Perricone, Paola Borgiani, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 199) with videos related to
Sort By:
Page
of 20
Arthritis Research & Therapy
|
June 15, 2018
Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus
Fulvia Ceccarelli, Carlo Perricone, Tania Colasanti, et al.
Annals of the Rheumatic Diseases
|
February 24, 2021
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists
Roberta Priori, Greta Pellegrino, Serena Colafrancesco, et al.
Plos One
|
September 7, 2017
The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus
Rossana Scrivo, Laura Massaro, Cristiana Barbati, et al.
Clinical and Experimental Rheumatology
|
May 19, 2026
Anti-neutrophil extracellular trap antibodies in autoimmune rheumatic diseases: a suitable biomarker of thrombosis in systemic lupus erythematosus
Silvia Mancuso, Luca Rapino, Valeria Riccieri, et al.
Annals of the Rheumatic Diseases
|
May 8, 2021
Response to: 'Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'' by Smerilli <i>et al</i>
Roberta Priori, Greta Pellegrino, Serena Colafrancesco, et al.
Seminars in Arthritis and Rheumatism
|
May 4, 2017
Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical assessment
Fulvia Ceccarelli, Carlo Perricone, Enrica Cipriano, et al.
Lupus
|
July 25, 2020
Caffeine intake influences disease activity and clinical phenotype in systemic lupus erythematosus patients
Valeria Orefice, Fulvia Ceccarelli, Cristiana Barbati, et al.
Ebiomedicine
|
November 9, 2020
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137<sup>+</sup>T-cells
Alessio Ugolini, Ilaria Grazia Zizzari, Fulvia Ceccarelli, et al.
Reumatismo
|
November 5, 2024
PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors
Cristina Garufi, Silvia Mancuso, Fulvia Ceccarelli, et al.
Journal of Immunology Research
|
January 23, 2016
Genetic Factors in Systemic Lupus Erythematosus: Contribution to Disease Phenotype
Fulvia Ceccarelli, Carlo Perricone, Paola Borgiani, et al.
Page
of 20